SLONIN JONATHAN 4

What Happened

Jonathan Slonin, Chief Medical Officer of Pacira BioSciences (PCRX), had 6,168 shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units. The withholding was recorded as a disposition on 2026-01-30 at $20.54 per share, for an aggregate value of approximately $126,691. This was a tax-withholding share surrender (not an open-market sale).

Key Details

• Transaction date: 2026-01-30
• Shares withheld/disposed: 6,168
• Price per share: $20.54
• Reported value: ~$126,691
• Transaction code: F (payment of exercise price or tax liability)
• Footnote: F1 — "Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award."
• Shares owned after the transaction: Not reported in this filing.
• Filing date: 2026-02-03 — filed within the required two-business-day window (timely).

Context

Share withholding to cover taxes on RSU vesting is a routine administrative action and differs from an open-market sale. Such withholding reduces the insider's share count but typically does not signal a deliberate decision to liquidate holdings or change investment sentiment.